1801.HK
1801.HK
KYG4818G1010
INNOVENT BIO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 13.041.523.000 9.421.888.000
38.4%
Cost of Revenue 1.756.019.000 1.510.210.000
16.3%
Gross Profit 11.285.504.000 7.911.678.000
42.6%
9.144.591.000 7.653.559.000
19.5%
Operating Income 2.140.913.000 258.119.000
729.4%
Pretax Income 838.924.000 -78.621.000
1167.0%
Net Income Common Stockholders 813.565.000 -94.631.000
959.7%
-- --
--
-- --
--
ende